NCT04187196View on ClinicalTrials.gov

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

September 28, 2022

Study Completion Date

September 28, 2022

Conditions
Atrial FibrillationAtrial Flutter
Interventions
DRUG

Propofol

Propofol will be given at an initial dose of 0.8 mg/kg followed by 20 mg every minute after 2 minutes, if adequate sedation is not achieved

DRUG

Methohexital

Methohexital will be given at an initial dose of 0.5 mg/kg, followed by 10 mg every minute after 2 minutes, if adequate sedation is not achieved

Trial Locations (1)

27157

Wake Forest Baptist Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT04187196 - Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion | Biotech Hunter | Biotech Hunter